Evaluation of Response of Dasatinib to Treat Mastocytosis

NCT00979160 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Systemic Mastocytosis

Interventions

DRUG: Dasatinib

Sponsor

Federico II University

Collaborators

[object Object]